C-JUN anticorps
-
- Antigène Voir toutes C-JUN (JUN) Anticorps
- C-JUN (JUN) (Jun Proto-Oncogene (JUN))
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp C-JUN est non-conjugé
-
Application
- Immunohistochemistry (IHC)
- Specificité
- C-Jun (Ab-73) antibody detects endogenous levels of total c-Jun protein.
- Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogène
- This antiserum was produced against synthesized non-phosphopeptide derived from human c-Jun around the phosphorylation site of serine 73 (L-A-SP-P-E).
- Top Product
- Discover our top product JUN Anticorps primaire
-
-
- Indications d'application
-
WB: 1:500~1:1000
IHC: 1:50~1:100. - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 100ug/100ul.
- Buffer
- Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 50% glycerol
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
-
-
Syphilis control--a continuing challenge." dans: The New England journal of medicine, Vol. 351, Issue 2, pp. 122-4, (2004) (PubMed).
: "c-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK)." dans: Oncogene, Vol. 23, Issue 55, pp. 8950-8, (2004) (PubMed).
: "Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73." dans: Nature, Vol. 354, Issue 6353, pp. 494-6, (1992) (PubMed).
: "
-
Syphilis control--a continuing challenge." dans: The New England journal of medicine, Vol. 351, Issue 2, pp. 122-4, (2004) (PubMed).
-
- Antigène
- C-JUN (JUN) (Jun Proto-Oncogene (JUN))
- Autre désignation
- c-Jun (JUN Produits)
- Synonymes
- anticorps AP-1, anticorps AP1, anticorps c-Jun, anticorps fj36h07, anticorps wu:fj36h07, anticorps zgc:65863, anticorps Junc, anticorps c-jun, anticorps CG2275, anticorps D-Jun, anticorps D-jun, anticorps D-jun/Jra, anticorps DJUN, anticorps DJun, anticorps Djun, anticorps Dmel\\CG2275, anticorps JRA, anticorps JUN, anticorps Jun, anticorps V, anticorps cJun, anticorps d-JRA, anticorps d-Jun, anticorps d-jun, anticorps dAP-1, anticorps dJRA, anticorps dJUN, anticorps dJra, anticorps dJun, anticorps djun, anticorps dm-Jun, anticorps jra, anticorps jun, anticorps l(2)46Ef, anticorps l(2)IA109, anticorps l(2R)IA109, anticorps Jun proto-oncogene, AP-1 transcription factor subunit, anticorps jun proto-oncogene S homeolog, anticorps jun proto-oncogene, anticorps Jun-related antigen, anticorps jun proto-oncogene L homeolog, anticorps JUN, anticorps Jun, anticorps jun.S, anticorps jun, anticorps Jra, anticorps jun.L
- Pathways
- Signalisation MAPK, Signalisation RTK, Signalisation WNT, Fc-epsilon Receptor Signaling Pathway, Activation of Innate immune Response, Myometrial Relaxation and Contraction, Skeletal Muscle Fiber Development, Protein targeting to Nucleus, Toll-Like Receptors Cascades, Autophagy, Signaling of Hepatocyte Growth Factor Receptor, BCR Signaling, S100 Proteins
-